COVID-19 death dashboards have become a fixture of daily television news broadcasts since March 2020. Whilst promoting daily death counters is unprecedented for any disease and clearly has deleterious effects on mental health, mortality trends may be the only accurate way to track the impact of the SARS-CoV-2 virus pandemic.
“The art and science of asking questions is the source of all knowledge” ~ Thomas Berger
China’s crackdown on its technology sector has set off alarms about Chinese political risk for investors.
In an interview with Bret Weinstein Ph.D., Dr. Pierre Kory, president and chief medical officer of the Frontline COVID-19 Critical Care Alliance discussed the importance of early treatment of COVID-19 and the shameful censoring of information about ivermectin.
From a Buffalo Hospital Room, a Grandmother Led the Global Fight for the Drug that Would Save Her Life and End the Pandemic.
The current expansion in prevalence of infectious Sars-CoV-2 variants is highly problematic because it erodes natural Ab-based, variant-nonspecific immunity in the non-vaccinated part of the population.
Los Angeles Times (LA Times) journalist Michael Hiltzik is the latest hired gun in the mainstream media to line up and take a pop-shot at the drug, Ivermectin.
In a breath of fresh air, a mainstream media opinion piece asks why the U.S. Food and Drug Administration (FDA) is denigrating a perfectly safe and effective drug?
A team of scientists at the University of Texas at Dallas developed a wearable sensor that can monitor the human body’s immune response to COVID-19 and other infections via the detection of molecules in human sweat.
On May 28, TrialSite reported on information regarding mRNA vaccine safety revealed by a freedom of information act (FOIA) request filed by a group of Canadian physicians who were concerned about COVID-19 mRNA vaccine safety.
Germany’s auto makers have announced vehicle sales are up in 2021, despite the COVID-19 pandemic and a sluggish economy. The most growth has come from electric vehicles (EVs), for which demand has skyrocketed.
Andrew Bannister’s article ‘Don’t mention Ivermectin; it’ll upset the vaccine rollout’ was published on BizNews.com in May. The article gained an extensive amount of traction, which isn’t all that surprising considering mainstream media’s lack of coverage on alternative Covid-19 treatment.
With the degree of passionate debate surrounding the use of ivermectin for the treatment and prevention of Covid-19, it is hard to believe that a mere seven months ago, the term ‘ivermectin’ was entirely foreign to most people.
TrialSite recently showcased what appears to be mounting safety issues with Sinopharm’s COVID-19 vaccine. Half-owned by the Chinese government, it’s one of a few controversial vaccines from China. Now doctors in the Southeastern Asian nation of Indonesia are dying after being vaccinated with CoronaVac, another COVID-19 vaccine developed by China’s Sinovac.
The recent upheaval in KwaZulu-Natal and Gauteng underscores an unmistakable truth: far from uplifting black South Africans and putting them on a par with their wealthier white compatriots who benefited from apartheid, over two decades of social engineering under the guise of Black Economic Empowerment (BEE) and related racial policies have produced dismal outcomes.
A reader recently asked me the following questions about the research I’ve conducted during the COVID-19 pandemic: “Have any of your fellow researchers disagreed with your findings?
After the ruin, disgrace, and misery of the recent anarchy, South Africans are witnessing something inspiring as shopping malls are rebuilt, shelves restocked, security enhanced, and business struggles back to normal.
President Cyril Ramaphosa has announced that several of South Africa’s lockdown regulations will be relaxed as the country moves to an adjusted level 3 lockdown with immediate effect.
A surge in Delta-variant driven COVID-19 cases concentrates in just a handful of states as there is, overall, an uptick in total cases across the United States.
An Israeli biotech has developed an investigational, proprietary protein oral delivery (POD™) technology in the development of oral vaccines that are now only available via an imposing injection.
